TokenPost topic

Remibrutinib

1 TokenPost story is tagged Remibrutinib. The newest appear first.

Latest Remibrutinib stories

• Novartis Sales Rise 4% as U.S. Patent or Exclusivity Expirations Are Estimated for 2031

  Kisqali and Kesimpta grew, while remibrutinib reduced relapse rates versus teriflunomide in two Phase III trials.

  Oct 30, 2026, 2:31 AM EDT · Business